{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:42:27Z","timestamp":1769575347948,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s00105-005-0995-5","type":"journal-article","created":{"date-parts":[[2005,7,15]],"date-time":"2005-07-15T13:26:50Z","timestamp":1121434010000},"page":"783-796","source":"Crossref","is-referenced-by-count":22,"title":["Lyme-Borreliose","Lyme borreliosis"],"prefix":"10.1007","volume":"56","author":[{"given":"H.","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"995_CR1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1099\/00207713-42-3-378","volume":"42","author":"Baranton","year":"1992","unstructured":"Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti JC, Assous M, Grimont PA (1992) Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42:378\u2013383","journal-title":"Int J Syst Bacteriol"},{"key":"995_CR2","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJM199511163332004","volume":"333","author":"Berglund","year":"1995","unstructured":"Berglund J, Eitrem R, Ornstein K et al. (1995) An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 333:1319\u20131327","journal-title":"N Engl J Med"},{"key":"995_CR3","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/JCM.36.9.2658-2665.1998","volume":"36","author":"Brettschneider","year":"1998","unstructured":"Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H (1998) Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 36:2658\u20132665","journal-title":"J Clin Microbiol"},{"key":"995_CR4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","volume":"216","author":"Burgdorfer","year":"1982","unstructured":"Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP (1982) Lyme disease-a tick-borne spirochetosis? Science 216:1317\u20131319","journal-title":"Science"},{"key":"995_CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199707313370501","volume":"337","author":"Dattwyler","year":"1997","unstructured":"Dattwyler RJ, Luft BJ, Kunkel MJ et al. (1997) Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 337:289\u2013294","journal-title":"N Engl J Med"},{"key":"995_CR6","unstructured":"Deutsche Gesellschaft f\u00fcr p\u00e4diatrische Infektiologie (Hrsg) (1997) AWMF. Leitlinie Lyme-Borreliose Handbuch 1997, 2. Aufl. Futuramed, M\u00fcnchen"},{"key":"995_CR7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/37551","volume":"390","author":"Fraser","year":"1997","unstructured":"Fraser CM, Casjens S, Huang WM et al. (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580\u2013586","journal-title":"Nature"},{"key":"995_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","volume":"281","author":"Gross","year":"1998","unstructured":"Gross DM, Forsthuber T, Tary-Lehmann M et al. (1998) Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281:703\u2013706","journal-title":"Science"},{"key":"995_CR9","unstructured":"Hofmann H (1990) Die Borrelia burgdorferi-Infektion der Haut-Untersuchungen zum Krankheitsspektrum, zur Labordiagnostik und zur Verbreitung der Infektion im Saarland: Habilitationsschrift, Med. Fakult\u00e4t der Universit\u00e4t des Saarlandes"},{"key":"995_CR10","first-page":"553","volume":"22","author":"Hofmann","year":"2002","unstructured":"Hofmann H (2002) Fr\u00fchdiagnose der Lyme-Borreliose. MMW Fortschr Med 22:553\u2013558","journal-title":"MMW Fortschr Med"},{"key":"995_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01713052","volume":"24","author":"Hofmann","year":"1996","unstructured":"Hofmann H (1996) Lyme Borreliosis-Problems of Serology. Infection 24:1\u20133","journal-title":"Infection"},{"key":"995_CR12","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/AAC.49.4.1294-1301.2005","volume":"49","author":"Hunfeld","year":"2005","unstructured":"Hunfeld KP, Ruzic-Sabljic E, Norris DE, Kraiczy P, Strle F (2005) In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob Agents Chemother 49:1294\u20131301","journal-title":"Antimicrob Agents Chemother"},{"key":"995_CR13","first-page":"847","volume":"123","author":"Kaiser","year":"1998","unstructured":"Kaiser R (1998) Prevention of early summer meningoencephalitis and Lyme borreliosis before and after tick bites. Dtsch Med Wochenschr 123:847\u2013853","journal-title":"Dtsch Med Wochenschr"},{"key":"995_CR14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","volume":"345","author":"Klempner","year":"2001","unstructured":"Klempner MS, Hu LT, Evans J et al. (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345:85\u201392","journal-title":"N Engl J Med"},{"key":"995_CR15","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1074\/jbc.M308343200","volume":"279","author":"Kraiczy","year":"2004","unstructured":"Kraiczy P, Hellwage J, Skerka C et al. (2004) Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem 279:2421\u20132429","journal-title":"J Biol Chem"},{"key":"995_CR16","first-page":"469","volume":"18","author":"Kramer","year":"1993","unstructured":"Kramer MD, Hassler D, Hofmann H, Wallich R, Schaible UE, Simon MM (1993) Therapie der Lyme Borreliose. Dtsch Med Wochenschr 18:469\u2013473","journal-title":"Dtsch Med Wochenschr"},{"key":"995_CR17","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/JCM.37.12.3990-3996.1999","volume":"37","author":"Liang","year":"1999","unstructured":"Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT (1999) Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol 37:3990\u20133996","journal-title":"J Clin Microbiol"},{"key":"995_CR18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-124-9-199605010-00002","volume":"124","author":"Luft","year":"1996","unstructured":"Luft BJ, Dattwyler RJ, Johnson RC et al. (1996) Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med 124:785\u2013791","journal-title":"Ann Intern Med"},{"key":"995_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM200107123450201","volume":"345","author":"Nadelman","year":"2001","unstructured":"Nadelman RB, Nowakowski J, Fish D et al. (2001) Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 345:79\u201384","journal-title":"N Engl J Med"},{"key":"995_CR20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archfami.9.6.563","volume":"9","author":"Nowakowski","year":"2000","unstructured":"Nowakowski J, McKenna D, Nadelman RB et al. (2000) Failure of treatment with cephalexin for Lyme disease. Arch Fam Med 9:563\u2013567","journal-title":"Arch Fam Med"},{"key":"995_CR21","first-page":"33","volume":"39","author":"Prophylaxe","year":"2005","unstructured":"Prophylaxe und Therapie der Lyme Borreliose (2005) Der Arzneimittelbrief 39:33\u201335","journal-title":"Der Arzneimittelbrief"},{"key":"995_CR22","first-page":"3768","volume":"10","author":"Schaible","year":"1994","unstructured":"Schaible UE, Kramer MD, Eichmann K, Modolell M, Moseteanu C, Simon MM (1990) Monoclonal antibodies specific for the outer surface protein. A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immun deficiency (scid) mice. Proc Natl Acad Sci USA 87 10:3768\u20133772","journal-title":"Proc Natl Acad Sci USA 87"},{"key":"995_CR23","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(03)14798-8","volume":"362","author":"Stanek","year":"2003","unstructured":"Stanek G, Strle F (2003) Lyme borreliosis. Lancet 362:1639\u20131647","journal-title":"Lancet"},{"key":"995_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","volume":"345","author":"Steere","year":"2001","unstructured":"Steere AC (2001) Lyme disease. N Engl J Med 345:115\u2013125","journal-title":"N Engl J Med"},{"key":"995_CR25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/jaut.2000.0495","volume":"16","author":"Steere","year":"2001","unstructured":"Steere AC, Gross D, Meyer AL, Huber BT (2001) Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. J Autoimmun 16:263\u2013268","journal-title":"J Autoimmun"},{"key":"995_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","volume":"339","author":"Steere","year":"1998","unstructured":"Steere AC, Sikand VK, Meurice F et al. (1998) Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 339:209\u2013215","journal-title":"N Engl J Med"},{"key":"995_CR27","unstructured":"Talaska T (2005) Zur Lyme-Borreliose im Land Brandenburg. Epidemiologisches Bulletin"},{"key":"995_CR28","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1128\/AAC.46.11.3637-3640.2002","volume":"46","author":"Terekhova","year":"2002","unstructured":"Terekhova D, Sartakova ML, Wormser GP, Schwartz I, Cabello FC (2002) Erythromycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother 46:3637\u20133640","journal-title":"Antimicrob Agents Chemother"},{"key":"995_CR29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.1988.tb31867.x","volume":"539","author":"Weber","year":"1988","unstructured":"Weber K, Preac-Mursic V, Neubert U, Thurmayr R, Herzer P, Wilske B, Schierz G, Marget W (1988) Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann N Y Acad Sci 539:324\u2013345","journal-title":"Ann N Y Acad Sci"},{"key":"995_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000086441","volume":"211","author":"Weissenbacher","year":"2005","unstructured":"Weissenbacher S, Ring J, Hofmann H (2005) Gabapentin for the Symptomatic treatment of Chronic Neuropathic Pain in Patients with Late-Stage Lyme Borreliosis; A Pilot Study. Dermatology 211:123\u2013127","journal-title":"Dermatology"},{"key":"995_CR31","unstructured":"Wilske B Z\u00f6ller L, Brade V (2000) MIQ 12 Lyme-Borreliose. Urban & Fischer, M\u00fcnchen"},{"key":"995_CR32","first-page":"1","volume":"1","author":"Wormser","year":"2000","unstructured":"Wormser GP, Nadelman RB, Dattwyler RJ et al. (2000) Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis 31 [Suppl 1]:1\u201314","journal-title":"Clin Infect Dis 31 Suppl"},{"key":"995_CR33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","volume":"138","author":"Wormser","year":"2003","unstructured":"Wormser GP, Ramanathan R, Nowakowski J et al. (2003) Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:697\u2013704","journal-title":"Ann Intern Med"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-0995-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-005-0995-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-0995-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T07:35:36Z","timestamp":1586331336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-005-0995-5"}},"subtitle":["Kutane Manifestationen","Cutaneous manifestation"],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1007\/s00105-005-0995-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}